A Clinical Study to Assess the Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Subjects Aged Over 1 Year Old to 18 Years Old.
Phase of Trial: Phase III
Latest Information Update: 19 Jan 2012
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Adimmune Corporation
- 19 Jan 2012 Actual end date Apr 2010 added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2009 New trial record